Sobel David, Caffery Philip, James Evelyn, Ortiz Rebecca, Peat Aidan, Tucci Chris, Pareek Gyan
Division of Urology, Department of Surgery, Maine Medical Center, Portland, ME, USA.
Tufts University School of Medicine, Boston, MA, USA.
Transl Androl Urol. 2025 May 30;14(5):1379-1390. doi: 10.21037/tau-2024-692. Epub 2025 May 27.
The American opioid epidemic continues and further efforts are needed to reduce unnecessary opioid prescriptions after urologic surgery. This is a pragmatic feasibility study to evaluate the safety and feasibility of opioid-free discharge after percutaneous nephrolithotomy (PCNL) utilizing a nonopioid protocol consisting of preoperative counseling, multimodal analgesics, and detailed postoperative instructions.
A prospective feasibility study (Clinicaltrials.gov: NCT04597619) was conducted at a single institution. All participants underwent single tract stented PCNL. Eligible participants were enrolled prospectively before and after implementation of the nonopioid protocol. Pre-intervention arm participants received opioid prescriptions at the discretion of the provider. Participants in the intervention arm underwent the nonopioid protocol. The primary outcome investigated was discharge following PCNL without a prescription for opioid pain medication. Other outcomes included postoperative pain, symptom questionnaire scores, emergency department (ED) visits for pain, and outpatient telephone calls or requests for prescription refills.
Fourteen participants were enrolled in the pre-intervention group. Of these, 10 (71%) were discharged with opioid prescriptions and 4 (29%) were discharged without opioids. Of the 10 discharged with opioids, 2 (14%) presented to the ED for pain concerns and received a new prescription for opioids. Six participants underwent intervention and received the nonopioid protocol. All participants (100%) in the intervention group were discharged without opioids. None (0%) presented to the ED for pain concerns.
This feasibility study demonstrates that patients undergoing PCNL via a standardized nonopioid pathway can be safely discharged without opioid prescriptions without impact on outpatient resources. Four participants in the pre-intervention group were discharged without opioids based on provider discretion, suggesting that the standard of care to include an opioid prescription may be changing.
美国的阿片类药物流行仍在持续,需要进一步努力减少泌尿外科手术后不必要的阿片类药物处方。这是一项务实的可行性研究,旨在评估经皮肾镜取石术(PCNL)后采用由术前咨询、多模式镇痛药物和详细术后指导组成的非阿片类药物方案实现无阿片类药物出院的安全性和可行性。
在单一机构进行了一项前瞻性可行性研究(Clinicaltrials.gov:NCT04597619)。所有参与者均接受单通道带支架PCNL。符合条件的参与者在非阿片类药物方案实施前后前瞻性入组。干预前组的参与者由提供者酌情开具阿片类药物处方。干预组的参与者采用非阿片类药物方案。研究的主要结局是PCNL术后无阿片类镇痛药物处方出院。其他结局包括术后疼痛、症状问卷评分、因疼痛到急诊科就诊以及门诊电话咨询或处方续开请求。
干预前组招募了14名参与者。其中,10名(71%)出院时开具了阿片类药物处方,4名(29%)出院时未使用阿片类药物。在10名出院时开具阿片类药物的参与者中,2名(14%)因疼痛问题到急诊科就诊并获得了新的阿片类药物处方。6名参与者接受了干预并采用了非阿片类药物方案。干预组的所有参与者(100%)出院时均未使用阿片类药物。无人(0%)因疼痛问题到急诊科就诊。
这项可行性研究表明,通过标准化非阿片类药物途径接受PCNL的患者可以安全出院且无需阿片类药物处方,同时不会影响门诊资源。干预前组有4名参与者根据提供者的判断出院时未使用阿片类药物,这表明包含阿片类药物处方的护理标准可能正在改变。